NCT05049538View on ClinicalTrials.gov

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Endometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Mucinous AdenocarcinomaEndometrial Serous AdenocarcinomaMalignant Uterine NeoplasmUterine Corpus Carcinosarcoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood and tissue samples

PROCEDURE

Liquid Biopsy

Undergo liquid biopsy

OTHER

Pap Smear

Undergo Pap smear

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER